tirzepatide
Get the evidence digestEvidence
EvidenceHow long until tirzepatide works: a week-by-week timelineMost people notice appetite changes in 1-2 weeks, real weight loss by week 4-8, and full effect around month 9-11. Here's the trial data behind that timeline.Read guide →EvidenceIs tirzepatide worth it? A real-numbers reality checkZepbound users lost 20.9% of body weight at 72 weeks in SURMOUNT-1. Here's what tirzepatide actually costs, does, and risks before you decide.Read guide →EvidenceNatural alternatives to tirzepatide: what actually worksBerberine, fiber, GLP-1 foods and lifestyle changes vs tirzepatide's 15-21% weight loss in trials. What the evidence really supports, and what doesn't.Read guide →EvidenceTirzepatide before and after: what the trials actually showWhat weight and A1C changes look like on tirzepatide, backed by SURMOUNT and SURPASS trial data, real timelines, and honest limits of before/after photos.Read guide →EvidenceTirzepatide first month: what to expect week by weekIn month one, most people start at 2.5 mg, lose 2-4% of body weight, and deal with mild GI side effects. Here's what the SURMOUNT trials actually show.Read guide →EvidenceTirzepatide FAQ: dosing, side effects, cost, and resultsAnswers to the most-asked tirzepatide questions: dosing, weight loss %, side effects, cost, Mounjaro vs Zepbound, and compounded vs brand, with trial data.Read guide →EvidenceTirzepatide in older adults: what the trial data showsSURPASS and SURMOUNT data on tirzepatide in adults over 65: efficacy, GI side effects, muscle loss risk, and dosing cautions explained with trial numbers.Read guide →EvidenceTirzepatide myths vs facts: what the trials actually showTirzepatide claims checked against SURMOUNT and SURPASS data: real weight loss numbers, side effect rates, and what's still unproven.Read guide →EvidenceTirzepatide pros and cons: what the trial data really showsTirzepatide cut A1C by up to 2.58% and body weight by up to 22.5% in trials, but GI side effects and a thyroid cancer warning are real. Full breakdown.Read guide →EvidenceTirzepatide reviews: what the trials and users actually reportReal tirzepatide reviews backed by trial data: 15-20% weight loss in SURMOUNT, common side effects, who it doesn't work for, and what long-term users say.Read guide →EvidenceTirzepatide success rate: what the trials actually showUp to 91% of Zepbound users lost 5%+ weight in SURMOUNT-1, and average loss hit 20.9% at 72 weeks. Here's the real data by dose and use case.Read guide →EvidenceTirzepatide: animal studies vs human trial evidenceRodent thyroid tumors vs SURPASS and SURMOUNT human data: what tirzepatide's animal studies actually showed, and why the FDA still approved it.Read guide →EvidenceTirzepatide before and after claims: what the trials actually showBefore and after photos aren't data. Here's what SURMOUNT and SURPASS actually recorded on tirzepatide weight loss and A1C over 36 to 72 weeks.Read guide →EvidenceTirzepatide clinical trials: what SURMOUNT and SURPASS showSURMOUNT-1 showed up to 22.5% weight loss at 72 weeks; SURPASS trials cut A1C by up to 2.4 points. Here's what the tirzepatide trial data actually says.Read guide →EvidenceTirzepatide human studies: what the trials actually showSURPASS and SURMOUNT enrolled over 15,000 people. Here's what the tirzepatide human studies found on weight loss, A1c, and side effects, trial by trial.Read guide →EvidenceTirzepatide mechanism of action: how the drug actually worksTirzepatide activates GLP-1 and GIP receptors together. Here's the receptor biology, trial data (SURMOUNT, SURPASS), and what it means for side effects and dosing.Read guide →EvidenceTirzepatide results: what the trial evidence showsSURMOUNT and SURPASS trial data on tirzepatide: up to 22.5% weight loss and A1C drops of 2.1 points. See the real numbers, timelines, and risks.Read guide →